cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.24136557.v1
title: ABSTRACT.docx

description: This research area includes synthesis of several nanostructured composite materials including transition metal nitrides, metal oxides Mxenes and 2D materials for electrochemical applications and fabrication of energy storage devices like batteries and supercapacitors with high efficiency to meet up the energy requirement of daily life.
DOI: 10.57967/hf/1110
title: test
DOI: 10.26180/23625249
title: Patient Reported Outcome Measures in multiple myeloma: real-time rePorTing to improve care

description: This is a feasibility study. The patient completes the MyPOS quality of life questionnaire, which should take 7 to 8 minutes to complete, either by tablet whilst in the waiting room for their appointment, online (by emailed link) within a week of their visit, or by hard copy, before 4 clinical visits. The patient indicates whether they completed the questionnaire on their own or with help from a friend/relative or a staff member. A summary of results of concern is generated from the Myeloma and Related Diseases Registry electronic database by<br> clicking a button and printing the summary. It is provided to the treating clinician by the study coordinator or clinic staff before the first 3 visits. The clinician is made aware that results from the questionnaire summary are to be taken into account in the patient's care by the study coordinator or by an explanatory statement left with the questionnaire summary for the clinician. Visits are:<br> T1: close to diagnosis, T2: T1 + 1 month, T3: T1 + 6 months, T4: T1 + 10 months.<br> After each of the first 3 visits the clinician completes an evaluation questionnaire to assess the feasibility of the intervention and after T3 the patient completes an evaluation questionnaire to assess the feasibility of the intervention.
DOI: 10.26180/23625249.v1
title: Patient Reported Outcome Measures in multiple myeloma: real-time rePorTing to improve care

description: This is a feasibility study. The patient completes the MyPOS quality of life questionnaire, which should take 7 to 8 minutes to complete, either by tablet whilst in the waiting room for their appointment, online (by emailed link) within a week of their visit, or by hard copy, before 4 clinical visits. The patient indicates whether they completed the questionnaire on their own or with help from a friend/relative or a staff member. A summary of results of concern is generated from the Myeloma and Related Diseases Registry electronic database by<br> clicking a button and printing the summary. It is provided to the treating clinician by the study coordinator or clinic staff before the first 3 visits. The clinician is made aware that results from the questionnaire summary are to be taken into account in the patient's care by the study coordinator or by an explanatory statement left with the questionnaire summary for the clinician. Visits are:<br> T1: close to diagnosis, T2: T1 + 1 month, T3: T1 + 6 months, T4: T1 + 10 months.<br> After each of the first 3 visits the clinician completes an evaluation questionnaire to assess the feasibility of the intervention and after T3 the patient completes an evaluation questionnaire to assess the feasibility of the intervention.
DOI: 10.26179/hw51-dj54
title: Amery Ice Shelf - hot water drill borehole, AM01 Brancker thermistor data - 2011/2012 data
DOI: 10.26179/8078-4d66
title: Amery Ice Shelf - hot water drill borehole, AM02 Brancker thermistor data - 2011/2012 data
DOI: 10.6084/m9.figshare.24136446.v1
title: Salmon counts and TMP

description: Transcriptome sequencing of lung tissue autopsy samples from 10 COVID-19 patients
DOI: 10.6084/m9.figshare.24136446.v2
title: Salmon counts and TMP

description: Transcriptome sequencing of lung tissue autopsy samples from 10 COVID-19 patients
DOI: 10.5281/zenodo.8342352
title: Inductively coupled plasma mass spectrometry of ions released from Ti40Zr10Cu36Pd14 bulk metallic glass

description: Inductively coupled plasma mass spectrometry (ICP-MS) of ions released from Ti40Zr10Cu36Pd14 bulk metallic glass after incubation in artificial saliva for 1 day, 3 days and 7 day to see how much it releases its ion into the medium.
description: The project received funding from Austrian Science Fund (FWF) under project grant I3937–N36, ERC Proof of Concept Grant TriboMetGlass (grant ERC-2019-PoC-862485). financial support by the Austrian Science Fund (FWF) under the project grant T891-N36. Thanks to European Commission for providing funding for this project under the Horizon 2020 research and innovation program for Marie Skłodowska-Curie Individual Fellowship, with the acronym "MAGIC" and grant agreement N. 892050.
DOI: 10.5281/zenodo.8342263
title: static water contact angle measurements of Ti40Zr10Cu36Pd14 bulk metallic glass and Ti6Al4V surfaces

description: static water contact angle measurements of Ti40Zr10Cu36Pd14 bulk metallic glass and Ti6Al4V surfaces: the measurments were first taken place on their etched surface and was repeated after they were incubated in orbital shaker in distilled water at 37˚C and 120 rpm for 48 hours.
description: The project received funding from Austrian Science Fund (FWF) under project grant I3937–N36, ERC Proof of Concept Grant TriboMetGlass (grant ERC-2019-PoC-862485). financial support by the Austrian Science Fund (FWF) under the project grant T891-N36. Thanks to European Commission for providing funding for this project under the Horizon 2020 research and innovation program for Marie Skłodowska-Curie Individual Fellowship, with the acronym "MAGIC" and grant agreement N. 892050.
DOI: 10.5281/zenodo.8342351
title: Inductively coupled plasma mass spectrometry of ions released from Ti40Zr10Cu36Pd14 bulk metallic glass

description: Inductively coupled plasma mass spectrometry (ICP-MS) of ions released from Ti40Zr10Cu36Pd14 bulk metallic glass after incubation in artificial saliva for 1 day, 3 days and 7 day to see how much it releases its ion into the medium.
description: The project received funding from Austrian Science Fund (FWF) under project grant I3937–N36, ERC Proof of Concept Grant TriboMetGlass (grant ERC-2019-PoC-862485). financial support by the Austrian Science Fund (FWF) under the project grant T891-N36. Thanks to European Commission for providing funding for this project under the Horizon 2020 research and innovation program for Marie Skłodowska-Curie Individual Fellowship, with the acronym "MAGIC" and grant agreement N. 892050.
DOI: 10.5281/zenodo.8342262
title: static water contact angle measurements of Ti40Zr10Cu36Pd14 bulk metallic glass and Ti6Al4V surfaces

description: static water contact angle measurements of Ti40Zr10Cu36Pd14 bulk metallic glass and Ti6Al4V surfaces: the measurments were first taken place on their etched surface and was repeated after they were incubated in orbital shaker in distilled water at 37˚C and 120 rpm for 48 hours.
description: The project received funding from Austrian Science Fund (FWF) under project grant I3937–N36, ERC Proof of Concept Grant TriboMetGlass (grant ERC-2019-PoC-862485). financial support by the Austrian Science Fund (FWF) under the project grant T891-N36. Thanks to European Commission for providing funding for this project under the Horizon 2020 research and innovation program for Marie Skłodowska-Curie Individual Fellowship, with the acronym "MAGIC" and grant agreement N. 892050.
DOI: 10.5281/zenodo.8342247
title: cytocompatibility analysis of Ti6Al4V and Ti40Zr10Cu36Pd14 bulk metallic glass

description: using Alamar blue to quantitatively measure the metabolic activity of fibroblast after 24 h and 48 h of cell culture on Ti6Al4V and Ti40Zr10Cu36Pd14 bulk metallic glass.
description: The project received funding from Austrian Science Fund (FWF) under project grant I3937–N36, ERC Proof of Concept Grant TriboMetGlass (grant ERC-2019-PoC-862485). financial support by the Austrian Science Fund (FWF) under the project grant T891-N36. Thanks to European Commission for providing funding for this project under the Horizon 2020 research and innovation program for Marie Skłodowska-Curie Individual Fellowship, with the acronym "MAGIC" and grant agreement N. 892050.
DOI: 10.5281/zenodo.8342208
title: High though-put proteomics analysis of dental plaque cultured on Ti40Zr10Cu36Pd14 bulk metallic glass and Ti6Al4V surface

description: High though-put proteomics analysis of dental plaque cultured on Ti40Zr10Cu36Pd14 bulk metallic glass and Ti6Al4V surface
description: The project received funding from Austrian Science Fund (FWF) under project grant I3937–N36, ERC Proof of Concept Grant TriboMetGlass (grant ERC-2019-PoC-862485). financial support by the Austrian Science Fund (FWF) under the project grant T891-N36. Thanks to European Commission for providing funding for this project under the Horizon 2020 research and innovation program for Marie Skłodowska-Curie Individual Fellowship, with the acronym "MAGIC" and grant agreement N. 892050.
DOI: 10.5281/zenodo.8342246
title: cytocompatibility analysis of Ti6Al4V and Ti40Zr10Cu36Pd14 bulk metallic glass

description: using Alamar blue to quantitatively measure the metabolic activity of fibroblast after 24 h and 48 h of cell culture on Ti6Al4V and Ti40Zr10Cu36Pd14 bulk metallic glass.
description: The project received funding from Austrian Science Fund (FWF) under project grant I3937–N36, ERC Proof of Concept Grant TriboMetGlass (grant ERC-2019-PoC-862485). financial support by the Austrian Science Fund (FWF) under the project grant T891-N36. Thanks to European Commission for providing funding for this project under the Horizon 2020 research and innovation program for Marie Skłodowska-Curie Individual Fellowship, with the acronym "MAGIC" and grant agreement N. 892050.
DOI: 10.5281/zenodo.8342207
title: High though-put proteomics analysis of dental plaque cultured on Ti40Zr10Cu36Pd14 bulk metallic glass and Ti6Al4V surface

description: High though-put proteomics analysis of dental plaque cultured on Ti40Zr10Cu36Pd14 bulk metallic glass and Ti6Al4V surface
description: The project received funding from Austrian Science Fund (FWF) under project grant I3937–N36, ERC Proof of Concept Grant TriboMetGlass (grant ERC-2019-PoC-862485). financial support by the Austrian Science Fund (FWF) under the project grant T891-N36. Thanks to European Commission for providing funding for this project under the Horizon 2020 research and innovation program for Marie Skłodowska-Curie Individual Fellowship, with the acronym "MAGIC" and grant agreement N. 892050.
DOI: 10.6084/m9.figshare.24136446.v3
title: Salmon count files

description: Transcriptome sequencing of lung tissue autopsy samples from 10 COVID-19 patients
DOI: 10.6084/m9.figshare.24137340
title: Supplementary Material for: Continuous erythropoietin receptor activator for the treatment of chronic dialysis patients with renal anemia in daily clinical practice in Poland: A non-interventional, multi-center, pragmatic NAVIGO trial

description: Background: Renal anemia is one of the most common complications of chronic kidney disease. This real-life study assessed the effectiveness of methoxy polyethylene glycol-epoetin beta, a continuous erythropoietin receptor activator (C.E.R.A.), for the treatment of chronic kidney disease (CKD)-associated anemia in patients receiving dialysis in daily clinical practice. Methods: 247 patients receiving chronic intermitted dialysis in 26 centers in Poland with CKD-associated symptomatic anemia, ESA-naïve, and with balanced iron stores in the investigators’ opinion were enrolled this real-life study. Over 12 months, the following data were collected: Hb concentration and dosage, route of administration and dosing scheme of C.E.R.A., dialysis adequacy, adverse events, iron therapy, and blood transfusions. Results: During the treatment, a Hb concentration of ≥10 g/dL was noted in 90.9% of hemodialysis patients (n=224) and 96.0% of peritoneal dialysis patients (n=23). At baseline, 7.8% of patients had a Hb concentration of 10–12 g/dL, which increased to 63.3% after 12 months. The median time when Hb concentration was maintained within 10–12 g/dL was 115.2 [IQR 49.1–188.7] days. A Hb concentration ≥12 g/dL was observed after 7 months of treatment in a maximum of 24.1% of hemodialysis patients, and 31.8% of peritoneal dialysis patients. The median time elapsed between the start of treatment and the first Hb concentration &gt;10 g/dL was 42.0 [21.0–78.2] days. C.E.R.A. was well tolerated. Conclusions: C.E.R.A. corrects CKD-associated anemia in dialysis patients, and maintains Hb levels within the recommended target range. The study also confirmed the acceptable safety profile of the drug. Study identifier at ClinicalTrials.gov: NCT01690455
DOI: 10.5281/zenodo.8100923
title: Genome annotation of Hibiscus trionum

description: <strong>Genome annotation of <em>Hibiscus trionum</em></strong> Author information<br> Shizuka Koshimizu<sup>1,2</sup>, Sachiko Masuda<sup>3</sup>, Arisa Shibata<sup>3</sup>, Takayoshi Ishii<sup>4</sup>, Ken Shirasu<sup>3</sup>, Atsushi Hoshino<sup>5,6</sup>, Masanori Arita<sup>1,2</sup> 1 Bioinformation and DDBJ Center, National Institute of Genetics, Mishima 411-8540, Japan<br> 2 Graduate Institute for Advanced Studies, SOKENDAI, Mishima 411-8540, Japan<br> 3 Center for Sustainable Resource Science, RIKEN, Yokohama 230-0045, Japan<br> 4 Arid Land Research Center, Tottori University, Tottori, 680-001, Japan<br> 5 National Institute for Basic Biology, Okazaki 444-8585, Japan<br> 6 Graduate Institute for Advanced Studies, SOKENDAI, Okazaki 444-8585, Japan <br> Contents<br> <strong>htrionum_v1.0_genome.fasta</strong>: Genome sequence<br> <strong>htrionum_v1.0_transcripts.gff3</strong>: Gene annotation<br> <strong>htrionum_v1.0_transcripts.gtf</strong>: Gene annotation<br> <strong>htrionum_v1.0_transcripts.fna</strong>: Transcript sequences<br> <strong>htrionum_v1.0_pep.faa</strong>: Protein sequences<br> <strong>Description.txt</strong>: Functional descriptions<br> <strong>InterProScan.txt</strong>: The results of InterProScan for all proteins Reference Genome and transcriptome analyses reveal genes involved in the formation of fine ridges on petal epidermal cells in <em>Hibiscus trionum</em> <em>DNA Research</em>, 2023;, dsad019, https://doi.org/10.1093/dnares/dsad019
DOI: 10.5281/zenodo.8100922
title: Genome annotation of Hibiscus trionum

description: <strong>Genome annotation of <em>Hibiscus trionum</em></strong> Author information<br> Shizuka Koshimizu<sup>1,2</sup>, Sachiko Masuda<sup>3</sup>, Arisa Shibata<sup>3</sup>, Takayoshi Ishii<sup>4</sup>, Ken Shirasu<sup>3</sup>, Atsushi Hoshino<sup>5,6</sup>, Masanori Arita<sup>1,2</sup> 1 Bioinformation and DDBJ Center, National Institute of Genetics, Mishima 411-8540, Japan<br> 2 Graduate Institute for Advanced Studies, SOKENDAI, Mishima 411-8540, Japan<br> 3 Center for Sustainable Resource Science, RIKEN, Yokohama 230-0045, Japan<br> 4 Arid Land Research Center, Tottori University, Tottori, 680-001, Japan<br> 5 National Institute for Basic Biology, Okazaki 444-8585, Japan<br> 6 Graduate Institute for Advanced Studies, SOKENDAI, Okazaki 444-8585, Japan <br> Contents<br> <strong>htrionum_v1.0_genome.fasta</strong>: Genome sequence<br> <strong>htrionum_v1.0_transcripts.gff3</strong>: Gene annotation<br> <strong>htrionum_v1.0_transcripts.gtf</strong>: Gene annotation<br> <strong>htrionum_v1.0_transcripts.fna</strong>: Transcript sequences<br> <strong>htrionum_v1.0_pep.faa</strong>: Protein sequences<br> <strong>Description.txt</strong>: Functional descriptions<br> <strong>InterProScan.txt</strong>: The results of InterProScan for all proteins Reference Genome and transcriptome analyses reveal genes involved in the formation of fine ridges on petal epidermal cells in <em>Hibiscus trionum</em> <em>DNA Research</em>, 2023;, dsad019, https://doi.org/10.1093/dnares/dsad019
DOI: 10.6084/m9.figshare.24136446
title: Transcriptome data

description: mRNA sequencing data of lung tissue autopsy samples from 10 COVID-19 patients and 5 healthy donors.mRNA sequencing data of SARS-CoV-2 infected golden hamster at different time points.
DOI: 10.6084/m9.figshare.24136446.v4
title: Salmon count files

description: Transcriptome sequencing of lung tissue autopsy samples from 10 COVID-19 patients
DOI: 10.6084/m9.figshare.24137280
title: Data and code shared for NGS

description: Code and data for the paper “Global crop production increase by soil organic carbon”Code authors: Dominic Woolf and Yuqing MaCode contact by domwoolf@gmail.com or yuqingma0114@gmail.comData authors: Mingsheng Fan, Yuqing Ma, Rong Li, Lei QiaoData contact by fanms@cau.edu.cnDescription: R scripts and data to quantify the causal effect of soil organic carbon (SOC) on crop yield of the three major crops (maize, wheat and rice). The R script and data aim to achieve three contents: (1) quantify the causal effect of SOC on crop yield; (2) analyze the major drivers of soil organic carbon yield gap; (3) make global extrapolation of SOC yield gap for the three studied crops.***Please install the necessary packages using the R script “Load Packages.R”.<br>1. Causal effect of SOC on crop yield(1) “Causal effect of SOC on crop yield by Random Forest.R”: R script used to establish the causal effect of SOC on crop yield by partial dependence using Random Forest.(2) “Causal effect of SOC on crop yield by Causal Forest.R”: R script used to estimate the effect size of SOC on crop yield by casual forest.(3) “Causal effect of SOC on crop yield under different N levels.R”: R script used to establish the casual effect of SOC on crop yield under different nitrogen input levels.(4) “Causal effect of SOC on crop yield under climate zones”: R script used to establish the casual effect of SOC on crop yield under global climate zones.(5) “data.csv”: CSV data used in this section.<br>2. Drivers of SOC yield gap(1) “Calculating SOC yield gap.R”: R script used to estimate SOC yield gap for each field trial.(2) “Determination of drivers for the SOC yield gaps.R”: R script used to quantify the driver of SOC yield gap based on field trial data by Random Forest.(3) “data.csv”: CSV data used in this section.<br>3. Global extrapolation of SOC yield gap(1) “Determination of coefficient and index of agreement for global extrapolation model.R”: R script used to analyze the model performance for global extrapolation(2) “Leave one out cross-validation to estimate prediction uncertainty for global extrapolation.R”: R script used to estimate the standard errors of predicted SOC yield gaps derived from global extrapolation models.(3) “Technical potential for global extrapolation.R”: R script used to estimate global yield increase under technical potential to increase SOC.(4) ”10.Unconstrained increase for global extrapolation.R”: R script used to estimate global yield increase under unconstrained increase in SOC.(5) “data.csv”: CSV data used in this section.(6) “Maize global data.csv”: The distribution of global maize cropping area used to estimate global maize yield increase derived from SOC.(7) “Wheat global data.csv”: The distribution of global wheat cropping area used to estimate global wheat yield increase derived from SOC.(8) “Rice global data.csv”: The distribution of global rice cropping area used to estimate global rice yield increase derived from SOC.
DOI: 10.6084/m9.figshare.24137412
title: Supplementary Material for: Impact of Isolated Coronary Microvascular Disease Diagnosed Using Various Measurement Modalities on Prognosis: An Updated Systematic Review and Meta- Analysis

description: Introduction: The main aim of this study was to investigate the impact of isolated coronary microvascular disease (CMD) as diagnosed via various modalities on prognosis. Method: A systematic literature review of PubMed, Embase, and Cochrane library databases was conducted to identify relevant studies published up to March 2023. Included studies were required to measure coronary microvascular function and report outcomes in patients without obstructive coronary artery disease (CAD) or any other cardiac pathological characteristics. The primary endpoint was all-cause mortality and the secondary endpoint was major adverse cardiac event (MACE). Pooled effects were calculated using random-effects models. Results: A total of 27 studies comprising 18,204 subjects were included in the meta-analysis. Indices of coronary microvascular function measurement included coronary angiography-derived index of microcirculatory resistance (caIMR), hyperemic microcirculatory resistance (HMR), coronary flow reserve (CFR), and so on. Patients with isolated CMD exhibited a significantly higher risk of mortality (OR: 2.97, 95% CI, 1.91–4.60, P &lt; 0.0001; HR: 3.38, 95% CI, 1.77–6.47, P = 0.0002) and MACE (OR: 5.82, 95% CI, 3.65–9.29, P＜0.00001; HR: 4.01, 95% CI, 2.59–6.20, P &lt; 0.00001) compared to those without CMD. Subgroup analysis by measurement modality demonstrated a consistent and robust pooled effect estimates in various subgroups. Conclusion: CMD is significantly associated with an elevated risk of mortality and MACE in patients without obstructive CAD or any other identifiable cardiac pathologies. The utilization of various measurement techniques may have potential advantages in the management of isolated CMD.
DOI: 10.6084/m9.figshare.24137412.v1
title: Supplementary Material for: Impact of Isolated Coronary Microvascular Disease Diagnosed Using Various Measurement Modalities on Prognosis: An Updated Systematic Review and Meta- Analysis

description: Introduction: The main aim of this study was to investigate the impact of isolated coronary microvascular disease (CMD) as diagnosed via various modalities on prognosis. Method: A systematic literature review of PubMed, Embase, and Cochrane library databases was conducted to identify relevant studies published up to March 2023. Included studies were required to measure coronary microvascular function and report outcomes in patients without obstructive coronary artery disease (CAD) or any other cardiac pathological characteristics. The primary endpoint was all-cause mortality and the secondary endpoint was major adverse cardiac event (MACE). Pooled effects were calculated using random-effects models. Results: A total of 27 studies comprising 18,204 subjects were included in the meta-analysis. Indices of coronary microvascular function measurement included coronary angiography-derived index of microcirculatory resistance (caIMR), hyperemic microcirculatory resistance (HMR), coronary flow reserve (CFR), and so on. Patients with isolated CMD exhibited a significantly higher risk of mortality (OR: 2.97, 95% CI, 1.91–4.60, P &lt; 0.0001; HR: 3.38, 95% CI, 1.77–6.47, P = 0.0002) and MACE (OR: 5.82, 95% CI, 3.65–9.29, P＜0.00001; HR: 4.01, 95% CI, 2.59–6.20, P &lt; 0.00001) compared to those without CMD. Subgroup analysis by measurement modality demonstrated a consistent and robust pooled effect estimates in various subgroups. Conclusion: CMD is significantly associated with an elevated risk of mortality and MACE in patients without obstructive CAD or any other identifiable cardiac pathologies. The utilization of various measurement techniques may have potential advantages in the management of isolated CMD.